CKI has been clinically approved by NMPA for treating cancer-induced pain (25), and CKI alone or it combined with chemotherapy or radiotherapy has been widely used and improved therapeutic and prognostic benefits (29, 31). The gene discussed is CHKA; the disease is cancer.